Finding the best ways to prevent heart disease in cancer survivors
Modeling Best Approaches for Cardiovascular Disease Prevention in Cancer Survivors
This study is looking for the best ways to help cancer survivors—especially those who had breast, prostate, or lung cancer—stay heart-healthy by understanding how their cancer treatments and other health factors work together.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10995346 on NIH RePORTER |
What this research studies
This research aims to identify effective strategies for preventing cardiovascular disease (CVD) among survivors of breast, prostate, and lung cancer. It focuses on understanding how traditional CVD risk factors and cancer treatments interact to affect heart health. By analyzing data from over 6 million cancer survivors, the study will explore tailored prevention methods that consider both cancer-related risks and the unique health challenges faced by these patients. The goal is to improve overall health outcomes and quality of life for cancer survivors.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have survived breast, prostate, or lung cancer and are at risk for cardiovascular disease.
Not a fit: Patients who are currently undergoing active cancer treatment or have other unrelated severe health conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the risk of heart disease in cancer survivors, improving their long-term health and survival rates.
How similar studies have performed: Previous research has shown promising results in using tailored prevention strategies for cardiovascular disease in other high-risk populations, suggesting potential success for this approach in cancer survivors.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Wisnivesky, Juan P — Icahn School of Medicine at Mount Sinai
- Study coordinator: Wisnivesky, Juan P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.